Eli Lilly & Co. (LLY)
1023.22
+2.66
(+0.26%)
USD |
NYSE |
Feb 19, 16:00
1022.95
-0.27
(-0.03%)
Pre-Market: 06:23
Eli Lilly EPS Diluted (Quarterly) : 7.024 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.455 |
| Biogen, Inc. | -0.3333 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Viking Therapeutics, Inc. | -1.383 |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 6.636B |
| Revenue (Quarterly) | 19.29B |
| Total Expenses (Quarterly) | 12.66B |
| Enterprise Value | 1.002T |
| Gross Profit Margin (Quarterly) | 82.52% |
| Profit Margin (Quarterly) | 34.40% |
| Earnings Yield | 2.21% |
| Operating Earnings Yield | 3.19% |
| Normalized Earnings Yield | 2.425 |